Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05642858 · ClinicalTrials.gov registry record · NA
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
A NA study of HIV and Cardiovascular Diseases, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 2
- Study locations
NCT05642858: Recruiting NA study of HIV and Cardiovascular Diseases, sponsored by University of California, San Francisco.
NCT05642858 is a NA study of HIV and Cardiovascular Diseases that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 260 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (41% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05642858, a NA study of HIV and Cardiovascular Diseases, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
Primary Outcome
Proportion of participants with blood pressure \< 130/80 mmHg as recorded in the electronic health record (EHR).
Conditions Studied
Interventions
- BEHAVIORAL Digital Educational Messaging
Study Locations (2)
California
- Zuckerberg San Francisco General Hospital - San Francisco
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2023-03-12 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT05642858 shows while recruiting
NCT05642858 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (41% lower).
The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Digital Educational Messaging is the first listed.
NCT05642858 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05642858 about?
NCT05642858 is a clinical study titled "Text Education About Cardiovascular Health and HIV (TEACH-HIV)". The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
What is the current status of trial NCT05642858?
This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2023-03-12. Estimated completion is 2026-07-01.
What conditions does trial NCT05642858 study?
This clinical trial studies the following conditions: HIV, Cardiovascular Diseases, Atherosclerosis, Human Immunodeficiency Virus.
What interventions are being tested in trial NCT05642858?
The interventions under investigation include: Digital Educational Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT05642858?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05642858 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05642858's enrollment target sits among peer trials
260 80th of 303 higher than 224 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
-
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI